Site icon Next Business 24

J.P. Morgan Maintains a Purchase on Legend Biotech Company (LEGN)

J.P. Morgan Maintains a Purchase on Legend Biotech Company (LEGN)


Legend Biotech Company (NASDAQ:LEGN) is without doubt one of the finest healthcare shares with the best upside. J.P. Morgan analyst Jessica Fye reiterated a bullish stance for Legend Biotech Company (NASDAQ:LEGN) on October 9, setting a $76 value goal.

Legend Biotech Company (LEGN): Amongst Takeover Rumors Hedge Funds Are Shopping for

Equally, TD Cowen analyst Yaron Werber additionally maintained a Purchase ranking on the inventory on October 3, maintaining the related value goal at $62.00. The analyst supported the optimistic ranking with the corporate’s future progress potential and strategic positioning.

He acknowledged that whereas Legend Biotech Company (NASDAQ:LEGN) is experiencing provide constraints with its Carvykti product at current, administration is assured in regards to the firm’s potential to beat these limitations by the tip of 2025, supported by deliberate capability expansions at key websites.

In accordance with him, this confidence might be seen in Legend Biotech Company’s (NASDAQ:LEGN) expectations to satisfy the consensus gross sales goal of $1.9 billion for the fiscal yr 2025.

Legend Biotech Company (NASDAQ:LEGN) is a clinical-stage firm that develops, discovers, manufactures, and commercializes novel therapies for oncology and different indications. It develops superior cell therapies throughout an elaborate vary of know-how platforms. The corporate operates within the US, China, and different geographical segments.

Whereas we acknowledge the potential of LEGN as an funding, we consider sure AI shares provide larger upside potential and carry much less draw back threat. When you’re searching for an especially undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.

READ NEXT: 30 Shares That Ought to Double in 3 Years and 11 Hidden AI Shares to Purchase Proper Now.

Disclosure: None. This text is initially revealed at Insider Monkey.

Keep forward of the curve with NextBusiness 24. Discover extra tales, subscribe to our publication, and be a part of our rising neighborhood at nextbusiness24.com

Exit mobile version